Goldman Sachs’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$662K Buy
2022
Q3
$379K Buy
2022
Q2
$126K Sell
2022
Q1
$120K Buy
2019
Q3
Sell
2019
Q2
$363K Buy
2018
Q3
Sell
2018
Q2
$276K Buy
2018
Q1
$214K Buy
2017
Q2
Sell
2017
Q1
$180K Buy